<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2024-9.4.13</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-4952</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОФТАЛЬМОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OPHTHALMOLOGY</subject></subj-group></article-categories><title-group><article-title>Роль Helicobacter pylori в развитии воспалительных заболеваний век</article-title><trans-title-group xml:lang="en"><trans-title>The role of Helicobacter pylori in the development of inflammatory eyelid diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9752-3494</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казанцева</surname><given-names>Э. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazantseva</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Казанцева Эльвира Павловна – аспирант кафедры «Глазных болезней» Медицинского института</p><p>117198, г. Москва, ул. Миклухо-Маклая, 6</p></bio><bio xml:lang="en"><p>Elvira P. Kazantseva – Postgraduate at the Department of Eye Diseases</p><p>Miklukho-Maklaya str. 6, Moscow 117198</p></bio><email xlink:type="simple">eli_fadeeva@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0988-1361</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фролов</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Frolov</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фролов Александр Михайлович – кандидат медицинских наук, доцент кафедры «Глазных болезней» Медицинского института</p><p>117198, г. Москва, ул. Миклухо-Маклая, 6</p></bio><bio xml:lang="en"><p>Aleksandr M. Frolov – Cand. Sc. (Med.), Associate Professor at the Department of Eye Diseases</p><p>Miklukho-Maklaya str. 6, Moscow 117198</p></bio><email xlink:type="simple">frolov_sasha@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9833-6236</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фролов</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Frolov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фролов Михаил Александрович – доктор медицинских наук, профессор, заведующий кафедрой «Глазных болезней» Медицинского института</p><p>117198, г. Москва, ул. Миклухо-Маклая, 6</p></bio><bio xml:lang="en"><p>Mikhail A. Frolov – Dr. Sc. (Med.), Professor, Head of the Department of Eye Diseases</p><p>Miklukho-Maklaya str. 6, Moscow 117198</p></bio><email xlink:type="simple">frolov_ma@rudn.university</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-2426-7326</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новикова Евгения Александровна – студентка</p><p>119991, г. Москва, ул. Большая Пироговская, 2, стр. 4</p></bio><bio xml:lang="en"><p>Evgeniya A. Novikova – Student</p><p>Bolshaya Pirogovskaya str. 2, build. 4, Moscow 119991</p></bio><email xlink:type="simple">novikova.evgen2000@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-2983-4891</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мугулов</surname><given-names>К. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Mugulov</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мугулов Курбан Шалбузович – студент</p><p>119991, г. Москва, ул. Большая Пироговская, 2, стр. 4</p></bio><bio xml:lang="en"><p>Kurban Sh. Mugulov – Student</p><p>Bolshaya Pirogovskaya str. 2, build. 4, Moscow 119991</p></bio><email xlink:type="simple">kmugulov777@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-2422-0183</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлова</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlova</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козлова Ксения Станиславовна – студентка</p><p>119991, г. Москва, ул. Большая Пироговская, 2, стр. 4</p></bio><bio xml:lang="en"><p>Ksenia S. Kozlova – Student</p><p>Bolshaya Pirogovskaya str. 2, build. 4, Moscow 119991</p></bio><email xlink:type="simple">kozlovaksk@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-8304-6878</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волчанский</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Volchanskiy</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Волчанский Кирилл Игоревич – студент</p><p>119991, г. Москва, ул. Большая Пироговская, 2, стр. 4</p></bio><bio xml:lang="en"><p>Kirill I. Volchanskiy – Student</p><p>Bolshaya Pirogovskaya str. 2, build. 4, Moscow 119991</p></bio><email xlink:type="simple">volrich@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-4725-5783</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Maximova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максимова Софья Андреевна – студентка</p><p>119991, г. Москва, ул. Большая Пироговская, 2, стр. 4</p></bio><bio xml:lang="en"><p>Sofya A. Maximova – Student</p><p>Bolshaya Pirogovskaya str. 2, build. 4, Moscow 119991</p></bio><email xlink:type="simple">soshamax@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-7862-8366</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пилипенко</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Pilipenko</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пилипенко Мирослава Олеговна – студентка</p><p>119991, г. Москва, ул. Большая Пироговская, 2, стр. 4</p></bio><bio xml:lang="en"><p>Miroslava O. Pilipenko – Student</p><p>Bolshaya Pirogovskaya str. 2, build. 4, Moscow 119991</p></bio><email xlink:type="simple">mr.kota2004@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов имени Патриса Лумумбы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia named after Patrice Lumumba</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2024</year></pub-date><volume>9</volume><issue>4</issue><fpage>108</fpage><lpage>116</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Казанцева Э.П., Фролов А.М., Фролов М.А., Новикова Е.А., Мугулов К.Ш., Козлова К.С., Волчанский К.И., Максимова С.А., Пилипенко М.О., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Казанцева Э.П., Фролов А.М., Фролов М.А., Новикова Е.А., Мугулов К.Ш., Козлова К.С., Волчанский К.И., Максимова С.А., Пилипенко М.О.</copyright-holder><copyright-holder xml:lang="en">Kazantseva E.P., Frolov A.M., Frolov M.A., Novikova E.A., Mugulov K.S., Kozlova K.S., Volchanskiy K.I., Maximova S.A., Pilipenko M.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/4952">https://www.actabiomedica.ru/jour/article/view/4952</self-uri><abstract><sec><title>Введение</title><p>Введение. Блефарит является одним из самых распространённых заболеваний глаз: на него приходится 23,3 % от общего числа пациентов с воспалительными заболеваниями глаз во всём мире. Среди этих пациентов 40,2 % обращаются за амбулаторной помощью. При этом заболеваемость блефаритом в 1,5–2 раза выше у женщин, чем у мужчин. Ведущими факторами развития блефарита являются как общие (поражение желудочно-кишечного тракта, сахарный диабет, гипертоническая болезнь, системное применение кортикостероидов и др.), так и местные (атопический и себорейный дерматиты или розацеа). Основными возбудителями данного заболевания являются представители Staphylococcus spp. (S. aureus, S. epidermidis). Как правило, заболевание манифестирует среди пациентов 30–50 лет, при этом у женщин в возрасте от 40 до 45 лет 80 % блефаритов оказываются стафилококковой природы. В настоящее время в литературных источниках имеются сообщения о потенциальной связи между инфекцией, вызванной Helicobacter pylori, и развитием хронического блефарита, однако данные весьма противоречивы.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Провести анализ особенностей взаимосвязи Helicobacter pylori и воспалительных заболеваний век.</p><p>Материалы и методы исследования. Проведены поиск и анализ литературных источников в базах данных Web of Science, PubMed, Google Scholar, а также в РИНЦ в период с 2000 по 2022 г.</p></sec><sec><title>Заключение</title><p>Заключение. В обзоре проанализированы и обобщены патогенетические механизмы связи хронического блефарита и Helicobacter pylori. Проведён анализ многочисленных исследований, которые дают основание предполагать возможную роль инфекции Helicobacter pylori в развитии и течении воспалительных заболеваний век (блефаритов). Основными патогенетическими аспектами в этих исследованиях являются: хроническое воспаление век и желудочно-кишечного тракта (антигенная мимикрия); выделение токсичных веществ из ротовой полости (аммиака, нитрита водорода, цианистого водорода и других вызывающих опосредованное воспаление конъюнктивы и хряща век); присутствие Helicobacter pylori в слезе.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Blepharitis is one of the most common eye diseases: it accounts for 23.3 % of the total number of patients with inflammatory eye diseases worldwide. 40.2 % of these patients seek outpatient care. The incidence of blepharitis is 1.5–2 times higher in women than in men. The leading factors in the development of blepharitis are both general (gastrointestinal tract diseases, diabetes mellitus, hypertension, systemic use of corticosteroids, etc.) and local (atopic and seborrheic dermatitis or rosacea). The main causative agents of this disease are Staphylococcus spp. (S. aureus, S. epidermidis). As a rule, the disease manifests itself in patients aged 30–50 years, while in women aged 40 to 45 years, 80 % of blepharitis are of staphylococcal origin. Currently, there are reports in the literature about apotential link between Helicobacter pylori infection and the development of chronic blepharitis, but the data are very contradictory.</p></sec><sec><title>The aim of the study</title><p>The aim of the study. To analyze the features of the relationship between Helicobacter pylori and inflammatory eyelid diseases.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. We conducted a search and analysis of literary sources in the Web of Science, PubMed and Google Scholar databases, as well as in the Russian Science Citation Index database for the period from 2000 to 2022.</p></sec><sec><title>Conclusion</title><p>Conclusion. The review analyzes and summarizes the pathogenic mechanisms of the relationship between chronic blepharitis and Helicobacter pylori. We carried out an analysis of numerous studies, which give grounds to assume a possible role of Helicobacter pylori infection in the development and course of inflammatory eyelid diseases (blepharitis). The main pathogenic aspects in these studies are: chronic inflammation of the eyelids and gastrointestinal tract (antigenic mimicry); excretion of toxic substances from the oral cavity (ammonia, hydrogen nitrite, hydrogen cyanide and other substances causing indirect inflammation of the conjunctiva and eyelid cartilage); the presence of Helicobacter pylori in tears.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Helicobacter pylori</kwd><kwd>хроническое воспаление</kwd><kwd>воспаление</kwd><kwd>дисфункция эндотелия</kwd><kwd>оттискная цитология</kwd><kwd>блефариты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Helicobacter pylori</kwd><kwd>chronic inflammation</kwd><kwd>inflammation</kwd><kwd>endothelial dysfunction</kwd><kwd>impression cytology</kwd><kwd>blepharitis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Baim AD, Movahedan A, Farooq AV, Skondra D. The microbiome and ophthalmic disease. Exp Biol Med (Maywood). 2019; 244(6): 419-429. doi: 10.1177/1535370218813616</mixed-citation><mixed-citation xml:lang="en">Baim AD, Movahedan A, Farooq AV, Skondra D. The microbiome and ophthalmic disease. Exp Biol Med (Maywood). 2019; 244(6): 419-429. doi: 10.1177/1535370218813616</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Izzotti A, Saccà SC, Bagnis A, Recupero SM. Glaucoma and Helicobacter pylori infection: Correlations and controversies. Br J Ophthalmol. 2009; 93(11): 1420-1427. doi: 10.1136/bjo.2008.150409</mixed-citation><mixed-citation xml:lang="en">Izzotti A, Saccà SC, Bagnis A, Recupero SM. Glaucoma and Helicobacter pylori infection: Correlations and controversies. Br J Ophthalmol. 2009; 93(11): 1420-1427. doi: 10.1136/bjo.2008.150409</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Saccà SC, Pascotto A, Venturino GM, Prigione G, Mastromarino A, Baldi F, et al. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci. 2006; 47(2): 501-508. doi: 10.1167/iovs.05-0323</mixed-citation><mixed-citation xml:lang="en">Saccà SC, Pascotto A, Venturino GM, Prigione G, Mastromarino A, Baldi F, et al. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci. 2006; 47(2): 501-508. doi: 10.1167/iovs.05-0323</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P. Association of Helicobacter pylori infection with primary Raynaud phenomenon. Lancet. 1996; 348(9032): 966-967. doi: 10.1016/S0140-6736(05)65386-X</mixed-citation><mixed-citation xml:lang="en">Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P. Association of Helicobacter pylori infection with primary Raynaud phenomenon. Lancet. 1996; 348(9032): 966-967. doi: 10.1016/S0140-6736(05)65386-X</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med. 2003; 198(8): 1147-1156. doi: 10.1084/jem.20030530</mixed-citation><mixed-citation xml:lang="en">Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med. 2003; 198(8): 1147-1156. doi: 10.1084/jem.20030530</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018; 24(29): 3204-3221. doi: 10.3748/wjg.v24.i29.3204</mixed-citation><mixed-citation xml:lang="en">Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018; 24(29): 3204-3221. doi: 10.3748/wjg.v24.i29.3204</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gürer MA, Erel A, Erbaş D, Cağlar K, Atahan C. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol. 2002; 41(11): 768-770. doi: 10.1046/j.13654362.2002.01452.x</mixed-citation><mixed-citation xml:lang="en">Gürer MA, Erel A, Erbaş D, Cağlar K, Atahan C. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol. 2002; 41(11): 768-770. doi: 10.1046/j.13654362.2002.01452.x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World JGastroenterol. 2014; 20(18): 5191-5204. doi: 10.3748/wjg.v20.i18.5191</mixed-citation><mixed-citation xml:lang="en">Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World JGastroenterol. 2014; 20(18): 5191-5204. doi: 10.3748/wjg.v20.i18.5191</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tirado-Hurtado I, Carlos C, Lancho L, Alfaro A, Ponce R, Schwarz LJ, et al. Helicobacter pylori: History and facts in Peru. Crit Rev OncolHematol. 2019; 134: 22-30. doi: 10.1016/j.critrevonc.2018.12.005</mixed-citation><mixed-citation xml:lang="en">Tirado-Hurtado I, Carlos C, Lancho L, Alfaro A, Ponce R, Schwarz LJ, et al. Helicobacter pylori: History and facts in Peru. Crit Rev OncolHematol. 2019; 134: 22-30. doi: 10.1016/j.critrevonc.2018.12.005</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Costa L, Corre S, Michel V, Le Luel K, Fernandes J, Ziveri J, et al. USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis. Gut. 2020; 69(9): 1582-1591. doi: 10.1136/gutjnl-2019-318640</mixed-citation><mixed-citation xml:lang="en">Costa L, Corre S, Michel V, Le Luel K, Fernandes J, Ziveri J, et al. USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis. Gut. 2020; 69(9): 1582-1591. doi: 10.1136/gutjnl-2019-318640</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018; 23(Suppl 1): e12514. doi: 10.1111/hel.12514</mixed-citation><mixed-citation xml:lang="en">Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018; 23(Suppl 1): e12514. doi: 10.1111/hel.12514</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sgambato D, Visciola G, Ferrante E, Miranda A, Romano L, Tuccillo C, et al. Prevalence of Helicobacter pylori infection in sexual partners of H. pylori-infected subjects: Role of gastroesophageal reflux. United European Gastroenterol J. 2018; 6(10): 1470-1476. doi: 10.1177/2050640618800628</mixed-citation><mixed-citation xml:lang="en">Sgambato D, Visciola G, Ferrante E, Miranda A, Romano L, Tuccillo C, et al. Prevalence of Helicobacter pylori infection in sexual partners of H. pylori-infected subjects: Role of gastroesophageal reflux. United European Gastroenterol J. 2018; 6(10): 1470-1476. doi: 10.1177/2050640618800628</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014; 19(Suppl 1): 1-5. doi: 10.1111/hel.12165</mixed-citation><mixed-citation xml:lang="en">Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014; 19(Suppl 1): 1-5. doi: 10.1111/hel.12165</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Leja M, Grinberga-Derica I, Bilgilier C, Steininger C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019; 24(Suppl 1): e12635. doi: 10.1111/hel.12635</mixed-citation><mixed-citation xml:lang="en">Leja M, Grinberga-Derica I, Bilgilier C, Steininger C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019; 24(Suppl 1): e12635. doi: 10.1111/hel.12635</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira E, et al. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol. 2020; 26(28): 40764093. doi: 10.3748/wjg.v26.i28.4076</mixed-citation><mixed-citation xml:lang="en">Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira E, et al. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol. 2020; 26(28): 40764093. doi: 10.3748/wjg.v26.i28.4076</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sharndama HC, Mba IE. Helicobacter pylori: An up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol. 2022; 53(1): 33-50. doi: 10.1007/s42770-021-00675-0</mixed-citation><mixed-citation xml:lang="en">Sharndama HC, Mba IE. Helicobacter pylori: An up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol. 2022; 53(1): 33-50. doi: 10.1007/s42770-021-00675-0</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Crowe SE. Helicobacter pylori infection. N Engl J Med. 2019; 380(12): 1158-1165. doi: 10.1056/NEJMcp1710945</mixed-citation><mixed-citation xml:lang="en">Crowe SE. Helicobacter pylori infection. N Engl J Med. 2019; 380(12): 1158-1165. doi: 10.1056/NEJMcp1710945</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N, et al. Helicobacter pylori infection: Current status and future prospects on diagnostic, therapeutic and control challenges. Antibiotics (Basel). 2023; 12(2): 191. doi: 10.3390/antibiotics12020191</mixed-citation><mixed-citation xml:lang="en">Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N, et al. Helicobacter pylori infection: Current status and future prospects on diagnostic, therapeutic and control challenges. Antibiotics (Basel). 2023; 12(2): 191. doi: 10.3390/antibiotics12020191</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? World J Gastroenterol. 2021; 27(7): 545-560. doi: 10.3748/wjg.v27.i7.545</mixed-citation><mixed-citation xml:lang="en">Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? World J Gastroenterol. 2021; 27(7): 545-560. doi: 10.3748/wjg.v27.i7.545</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric cancer: Pathogenetic mechanisms. Int J Mol Sci. 2023; 24(3): 2895. doi: 10.3390/ijms24032895</mixed-citation><mixed-citation xml:lang="en">Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric cancer: Pathogenetic mechanisms. Int J Mol Sci. 2023; 24(3): 2895. doi: 10.3390/ijms24032895</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mobley HL, Garner RM, Bauerfeind P. Helicobacter pylori nickel-transport gene nixA: Synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol Microbiol. 1995; 16(1): 97-109. doi: 10.1111/j.1365-2958.1995.tb02395.x</mixed-citation><mixed-citation xml:lang="en">Mobley HL, Garner RM, Bauerfeind P. Helicobacter pylori nickel-transport gene nixA: Synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol Microbiol. 1995; 16(1): 97-109. doi: 10.1111/j.1365-2958.1995.tb02395.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Idowu S, Bertrand PP, Walduck AK. Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation. Helicobacter. 2022; 27(3): e12891. doi: 10.1111/hel.12891</mixed-citation><mixed-citation xml:lang="en">Idowu S, Bertrand PP, Walduck AK. Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation. Helicobacter. 2022; 27(3): e12891. doi: 10.1111/hel.12891</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World JGastroenterol. 2019; 25(37): 5578-5589. doi: 10.3748/wjg.v25.i37.5578</mixed-citation><mixed-citation xml:lang="en">de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World JGastroenterol. 2019; 25(37): 5578-5589. doi: 10.3748/wjg.v25.i37.5578</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y, Wang QL, Cheng DD, Xu WT, Lu NH. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front Cell Infect Microbiol. 2016; 6: 159. doi: 10.3389/fcimb.2016.00159</mixed-citation><mixed-citation xml:lang="en">Huang Y, Wang QL, Cheng DD, Xu WT, Lu NH. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front Cell Infect Microbiol. 2016; 6: 159. doi: 10.3389/fcimb.2016.00159</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hathroubi S, Hu S, Ottemann KM. Genetic requirements and transcriptomics of Helicobacter pylori biofilm formation on abiotic and biotic surfaces. NPJ Biofilms Microbiomes. 2020; 6(1): 56. doi: 10.1038/s41522-020-00167-3</mixed-citation><mixed-citation xml:lang="en">Hathroubi S, Hu S, Ottemann KM. Genetic requirements and transcriptomics of Helicobacter pylori biofilm formation on abiotic and biotic surfaces. NPJ Biofilms Microbiomes. 2020; 6(1): 56. doi: 10.1038/s41522-020-00167-3</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019; 11(11): 677. doi: 10.3390/toxins11110677</mixed-citation><mixed-citation xml:lang="en">Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019; 11(11): 677. doi: 10.3390/toxins11110677</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, et al. Helicobacter pylori virulence factors – Mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells. 2020; 10(1): 27. doi: 10.3390/cells10010027</mixed-citation><mixed-citation xml:lang="en">Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, et al. Helicobacter pylori virulence factors – Mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells. 2020; 10(1): 27. doi: 10.3390/cells10010027</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017; 22(Suppl 1). doi: 10.1111/hel.12405</mixed-citation><mixed-citation xml:lang="en">Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017; 22(Suppl 1). doi: 10.1111/hel.12405</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Niu Q, Zhu J, Yu X, Feng T, Ji H, Li Y, et al. Immune response in H. pylori-associated gastritis and gastric cancer. Gastroenterol Res Pract. 2020; 2020: 9342563. doi: 10.1155/2020/9342563</mixed-citation><mixed-citation xml:lang="en">Niu Q, Zhu J, Yu X, Feng T, Ji H, Li Y, et al. Immune response in H. pylori-associated gastritis and gastric cancer. Gastroenterol Res Pract. 2020; 2020: 9342563. doi: 10.1155/2020/9342563</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hamzah DN, Aljanaby AAJ. Immune response in patients infected with Helicobacter pylori in Al-Najaf City, Iraq. Int J Pharmaceut Res. 2020; 12(3): 901-911. doi: 10.31838/ijpr/2020.12.03.139</mixed-citation><mixed-citation xml:lang="en">Hamzah DN, Aljanaby AAJ. Immune response in patients infected with Helicobacter pylori in Al-Najaf City, Iraq. Int J Pharmaceut Res. 2020; 12(3): 901-911. doi: 10.31838/ijpr/2020.12.03.139</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Moyat M, Velin D. Immune responses to Helicobacter pylori infection. World J Gastroenterol. 2014; 20(19): 5583-5593. doi: 10.3748/wjg.v20.i19.5583</mixed-citation><mixed-citation xml:lang="en">Moyat M, Velin D. Immune responses to Helicobacter pylori infection. World J Gastroenterol. 2014; 20(19): 5583-5593. doi: 10.3748/wjg.v20.i19.5583</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuo Y, Kido Y, Yamaoka Y. Helicobacter pylori outer membrane protein-related pathogenesis. Toxins (Basel). 2017; 9(3): 101. doi: 10.3390/toxins9030101</mixed-citation><mixed-citation xml:lang="en">Matsuo Y, Kido Y, Yamaoka Y. Helicobacter pylori outer membrane protein-related pathogenesis. Toxins (Basel). 2017; 9(3): 101. doi: 10.3390/toxins9030101</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Eberhardt M, Rammohan G. Blepharitis. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation><mixed-citation xml:lang="en">Eberhardt M, Rammohan G. Blepharitis. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Daković Z, Vesić S, Vuković J, Milenković S, JankovićTerzić K, Dukić S, et al. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: A case series. Acta Dermatovenerol Alp Pannonica Adriat. 2007; 16(2): 83-86.</mixed-citation><mixed-citation xml:lang="en">Daković Z, Vesić S, Vuković J, Milenković S, JankovićTerzić K, Dukić S, et al. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: A case series. Acta Dermatovenerol Alp Pannonica Adriat. 2007; 16(2): 83-86.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: New concepts in classification and treatment. Am J Clin Dermatol. 2021; 22(4): 457-465. doi: 10.1007/s40257-021-00595-7</mixed-citation><mixed-citation xml:lang="en">van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: New concepts in classification and treatment. Am J Clin Dermatol. 2021; 22(4): 457-465. doi: 10.1007/s40257-021-00595-7</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Bernardes TF, Bonfioli AA. Blepharitis. Semin Ophthalmol. 2010; 25(3): 79-83. doi: 10.3109/08820538.2010.488562</mixed-citation><mixed-citation xml:lang="en">Bernardes TF, Bonfioli AA. Blepharitis. Semin Ophthalmol. 2010; 25(3): 79-83. doi: 10.3109/08820538.2010.488562</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu W, Hamblin MR, Wen X. Role of the skin microbiota and intestinal microbiome in rosacea. Front Microbiol. 2023; 14: 1108661. doi: 10.3389/fmicb.2023.1108661</mixed-citation><mixed-citation xml:lang="en">Zhu W, Hamblin MR, Wen X. Role of the skin microbiota and intestinal microbiome in rosacea. Front Microbiol. 2023; 14: 1108661. doi: 10.3389/fmicb.2023.1108661</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Farshchian M, Daveluy S. Rosacea. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation><mixed-citation xml:lang="en">Farshchian M, Daveluy S. Rosacea. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Batioglu-Karaaltin A, Saatci O, Akpinar M, Celik MO, Develioglu O, et al. Helicobacter pylori in lacrimal secretions. Ear Nose Throat J. 2016; 95(3): E8-E11. doi: 10.1177/014556131609500303</mixed-citation><mixed-citation xml:lang="en">Batioglu-Karaaltin A, Saatci O, Akpinar M, Celik MO, Develioglu O, et al. Helicobacter pylori in lacrimal secretions. Ear Nose Throat J. 2016; 95(3): E8-E11. doi: 10.1177/014556131609500303</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
